Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20163987 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCC
Condition: Carcinoma, Renal Cell
Intervention: Drug: Gemcitabine, Capecitabine and Sorafenib (6 cycles)

Indicates status has not been verified in more than two years